Lantus and Maxitrol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lantus (insulin glargine recombinant) and Maxitrol (dexamethasone; neomycin sulfate; polymyxin b sulfate). Common drug interactions include blindness unilateral among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Lantus and Maxitrol. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.

What is Maxitrol?

Maxitrol has active ingredients of dexamethasone; neomycin sulfate; polymyxin b sulfate. eHealthMe is studying from 986 Maxitrol users. Check the latest studies of Maxitrol.



On Jul, 11, 2026

14 people who take Lantus and Maxitrol together, and have interactions are studied.

Lantus and Maxitrol drug interactions.

What are the common drug interactions of Lantus and Maxitrol, by gender? *:

female:

  1. Blindness unilateral
  2. Blood glucose increased
  3. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  4. Diabetes mellitus inadequate control
  5. Diabetic glaucoma (disease that damages the eye's optic nerve caused by diabetes)
  6. Drug hypersensitivity
  7. Headache (pain in head)
  8. Hyperkalaemia (damage to or disease of the kidney)
  9. Macular hole (small break in the macula, the central area of the retina)
  10. Malaise (a feeling of general discomfort or uneasiness)

male:

  1. Death
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Chest pain
  4. Chronic kidney disease
  5. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  6. Eye oedema (swelling or thickening of the macula, the area of the retina responsible for central vision)
  7. Fall
  8. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  9. Lung adenocarcinoma (a form of non-small cell lung cancer)
  10. Lung infection

What are the common drug interactions of Lantus and Maxitrol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Atrioventricular block second degree (heart block second degree)
  2. Chest pain
  3. Hypertension (high blood pressure)
  4. Lung infection
  5. Nausea (feeling of having an urge to vomit)
  6. Nephrolithiasis (calculi in the kidneys)
  7. Pneumonia
  8. Pyelonephritis (inflammation of kidney caused by bacteria)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)

50-59:

  1. Death

60+:

  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  3. Diabetes mellitus inadequate control
  4. Diabetic glaucoma (disease that damages the eye's optic nerve caused by diabetes)
  5. Drug hypersensitivity
  6. Eye oedema (swelling or thickening of the macula, the area of the retina responsible for central vision)
  7. Fall
  8. Headache (pain in head)
  9. Hyperkalaemia (damage to or disease of the kidney)
  10. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 4 people, 28.57%
  2. High Blood Pressure: 4 people, 28.57%
  3. Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 3 people, 21.43%
  4. High Blood Cholesterol: 3 people, 21.43%
  5. Neuropathy Peripheral (surface nerve damage): 2 people, 14.29%
  6. Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 14.29%
  7. Eye Injury: 2 people, 14.29%
  8. Kidney Stones: 2 people, 14.29%
  9. Multiple Myeloma (cancer of the plasma cells): 2 people, 14.29%
  10. Gout (uric acid crystals building up in the body): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Lantus and Maxitrol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lantus and Maxitrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lantus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Maxitrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lantus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Maxitrol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on insulin glargine recombinant and dexamethasone; neomycin sulfate; polymyxin b sulfate (the active ingredients of Lantus and Maxitrol, respectively), and Lantus and Maxitrol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: